These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9190550)

  • 1. [Immune responses of IgG, IgA and anti-CagA IgG to Helicobacter pylori in dyspeptic and peptic ulcer patients].
    Tamássy K; Auli P; Fekete B; Antonello C
    Orv Hetil; 1997 Apr; 138(16):985-8. PubMed ID: 9190550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Helicobacter pylori CagA antigen antibodies].
    Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
    Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].
    Yang G; Hu F; Jia J
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of Helicobacter pylori CagA-positive strains: gastroduodenal peptic lesions marker.
    Martín Guerrero JM; Hergueta Delgado P; Esteban Carretero J; Romero Castro R; Pellicer Bautista FJ; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2000 Mar; 92(3):160-73. PubMed ID: 10799946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori genotypes and their association with host's immune response].
    Garza-González E; Pérez-Pérez GI; Tijerina-Menchaca R; Maldonado-Garza HJ; Bosques-Padilla FJ
    Rev Gastroenterol Mex; 2002; 67(3):155-60. PubMed ID: 12653051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.
    Sezikli M; Guliter S; Apan TZ; Aksoy A; Keles H; Ozkurt ZN
    Int J Clin Pract; 2006 Oct; 60(10):1239-43. PubMed ID: 16669834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between mucosal levels of Helicobacter pylori-specific IgA, interleukin-8 and gastric inflammation.
    Zhang QB; Etolhi G; Dawodu JB; Gemmell CG; Russell RI
    Clin Sci (Lond); 1999 Apr; 96(4):409-14. PubMed ID: 10087249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
    Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
    Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients.
    Parente F; Imbesi V; Maconi G; Cucino C; Sangaletti O; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1998 Jul; 93(7):1073-9. PubMed ID: 9672333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies against heat-stable antigens from Helicobacter pylori in patients with dyspeptic symptoms and normal persons.
    Andersen LP; Raskov H; Elsborg L; Holck S; Justesen T; Fischer Hansen B; Møller Nielsen C; Gaarslev K
    APMIS; 1992 Sep; 100(9):779-89. PubMed ID: 1389098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can anti-Helicobacter pylori and anti-CagA antibodies be used to select patients with dyspepsia for gastroscopy?
    Manjunath SM; Desai ND; Alexander J; Patil S; Ughade S; Sawant P
    Trop Gastroenterol; 2006; 27(3):122-6. PubMed ID: 17310555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori density and cagA status in cirrhotic patients: a case-control study.
    Zullo A; Sanchez-Mete L; Hassan C; Diana F; Festuccia F; Attili AF; Morini S
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1174-8. PubMed ID: 15377296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CagA and anti-VacA antibodies in Helicobacter pylori-infected patients with and without peptic ulcer disease in Serbia and Montenegro.
    Sokic-Milutinovic A; Wex T; Todorovic V; Milosavljevic T; Malfertheiner P
    Scand J Gastroenterol; 2004 Mar; 39(3):222-6. PubMed ID: 15074390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
    Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
    Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori cagA and iceA genotypes status and risk of peptic ulcer in Saudi patients.
    Momenah AM; Tayeb MT
    Saudi Med J; 2007 Mar; 28(3):382-5. PubMed ID: 17334464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.